SynthesisBMC cancer2021

Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review.

Francesco Spagnolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.